When Are Topical Corticosteroids Recommended for Mycosis Fungoides?

Mycosis fungoides is a type of cutaneous T-cell lymphoma that affects the skin. Early lesions can look like persistent dry patches, plaques, or areas of altered colour, so diagnosis and follow-up matter. A topical corticosteroid can calm itch and inflammation in a treated area, but it is not a complete plan for the underlying condition and should not replace specialist monitoring.

The medicine chosen depends on the lesion, body site, extent of skin involvement, and other treatments being considered. Do not start, stop, or change a steroid without telling the clinician responsible for your care, especially if a biopsy or another skin-directed treatment is planned.

Apply the medicine only to the areas and at the frequency specified. Wash hands after use, avoid eyes and mucosal surfaces unless specifically instructed, and use moisturiser as advised for dryness. Keep a record of new patches, changes in texture or colour, itch, tenderness, and any treatment reaction so these details can be discussed at follow-up.

Do not cover treated areas tightly or use leftover steroid products from another rash. A patch that looks calmer may still need review, because appearance alone does not show how the condition is behaving.

Contact the treating team promptly for rapidly changing patches, new widespread redness, significant pain, open skin, drainage, fever, or swollen glands. Seek urgent help for breathing difficulty, facial or throat swelling, severe eye symptoms, or a sudden extensive reaction to a product.

Ask which lesions should receive treatment, how the course fits with biopsies or other skin-directed therapy, and what changes should be reported between visits. Ask how to manage itch, how often follow-up is needed, and whether a new patch requires examination rather than self-treatment.